Tributyltin exposure alters cytokine levels in mouse serum

References

• Alderson M, Tough T, Ziegler S, Grabstein K. 1991. Interleukin-7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes. J Exp Med. 173:923–930.
   PubMed Web of Science ®Google Scholar
• Alzieu C. 2000. Environmental impact of TBT: The French experience. Sci Total Environ. 258:99–102.
   PubMed Web of Science ®Google Scholar
• Bikker A, Hack CE, Lafeber FP, van Roon JA. 2012. IL-7: A key mediator in T-cell-driven autoimmunity, inflammation, and tissue destruction. Curr Pharm Des. 18:2347–3456.
   PubMed Web of Science ®Google Scholar
• Billiau A, Matthys P. 2009. IFNγ: A historical perspective. Cytokine Growth Factor Rev. 20:97–113.
   PubMed Web of Science ®Google Scholar
• Brown S, Whalen M. 2015. Tributyltin alters secretion of IL-1β from human immune cells. J Appl Toxicol. 35:895–908.
   PubMed Web of Science ®Google Scholar
• Bryan GW, Gibbs PE, Huggett RJ, Curtis LA, Bailey DS, Dauer DM. 1989. Effects of tributyltin pollution on the mud snail. Ilyanassa obsoleta, from the York River and Sarah Creek, Chesapeake Bay. Marine Poll Bull. 20:458–462.
   Web of Science ®Google Scholar
• Coussens LM, Werb Z. 2002. Inflammation and cancer. Nature 420:860–867.
   PubMed Web of Science ®Google Scholar
• Darwich L, Coma G, Peña R, Bellido R., Blanco EJ, Este JA, Borras FE, Clotet B, Ruiz L, Rosell A, et al 2008. Secretion of IFNγ by human macrophages demonstrated at single-cell level after co-stimulation with IL-12 plus IL-18. Immunology. 126:386–393.
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Petersen S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: Comparison with IL-4 and modulation by IFNγ or IL-10. J Immunol. 151:6370–6381.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. 2000. Pro-inflammatory cytokines. Chest. 118:503–508.
   PubMed Web of Science ®Google Scholar
• Dudimah FD, Odman-Ghazi SO, Hatcher F, Whalen MM. 2007. Effect of tributyltin (TBT) on ATP levels in human natural killer cells: Relationship to TBT-induced decreases in NK function. J Appl Toxicol. 27:86–94.
   PubMed Web of Science ®Google Scholar
• Fehniger TA, Cooper MA, Caligiuri MA. 2002. IL-2 and IL-15: Immunotherapy for cancer. Cytokine Growth Factor Rev. 13:169–183.
   PubMed Web of Science ®Google Scholar
• Gabay C, Lamacchia C, Palmer G. 2010. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 6:232–241.
   PubMed Web of Science ®Google Scholar
• Gee K, Guzzo C, Che Mat NF, Ma W, Kumar A. 2009. The IL-12 family of cytokines in infection, inflammation, and autoimmune disorders. Inflamm Allergy Drug Targets. 1:40–52.
   Google Scholar
• Ghoneum M, Hussein AE, Gill G, Alfred LJ. 1990. Suppression of murine natural killer cell activity by tributyltin: In vivo and in vitro assessment. Environ Res. 52:178–186.
   PubMed Web of Science ®Google Scholar
• Gipperth L. 2009. The legal design of the international and European Union ban on tributyltin antifouling paint: Direct and indirect effects. J Environ Manage. 90:S86–S95.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. 2010. Immunity, inflammation and cancer. Cell. 140:883–899.
   PubMed Web of Science ®Google Scholar
• Gui-Bin J, Qun-Fang Z, Bin H. 2000. Speciation of organotin compounds, total tin, and major trace metal elements in poisoned human organs by gas chromatography-flame photometric detector and inductively coupled plasma-mass spectrometry. Environ Sci Technol. 34:2697–2705.
   Web of Science ®Google Scholar
• Hoch M. 2001. Organotin compounds in the environment – an overview. Appl GeoChem. 16:719–743.
   Web of Science ®Google Scholar
• Hou L, Jie Z, Liang Y, Desai M, Soong L, Sun J. 2015. Type 1 IFN-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis. Cell Mol Immunol. 12:213–221.
   PubMed Web of Science ®Google Scholar
• Hurt K, Hurd-Brown T, Whalen M. 2013. Tributyltin and dibutyltin alter secretion of TNFα from human natural killer (NK) cells and a mixture of T-cells and NK cells. J Appl Toxicol. 33:503–510.
   PubMed Web of Science ®Google Scholar
• IPCS. 1999. Concise International Chemical Assessment Documents, No. 14, Tributyltin Oxide. Geneva: World Health Organization.
   Google Scholar
• Jana M, Mondal S, Jana A, Pahan K. 2014. Interleukin-12 (IL-12), but not IL-23, induces the expression of IL-7 in microglia and macrophages: Implications for multiple sclerosis. Immunology. 141:549–563.
   PubMed Web of Science ®Google Scholar
• Jin JO, Shinohara Y, Yu Q. 2013. Innate immune signaling induces IL-7 production from salivary gland cells and accelerates the development of primary Sjögren’s syndrome in a mouse model. PLoS One. 8:e77605.
   PubMed Web of Science ®Google Scholar
• Kannan K, Senthilkumar K, Giesy J. 1999. Occurrence of butyltin compounds in human blood. Environ Sci Technol. 33:1776–1779.
   Web of Science ®Google Scholar
• Kannan K, Tanabe S, Tatsukawa R. 1995. Occurrence of butyltin residues in certain foodstuffs. Bull Environ Contam Toxicol. 55:510–516.
   PubMed Web of Science ®Google Scholar
• Kimbrough RD. 1976. Toxicity and health effects of selected organotin compounds: A review. Environ Health Perspect. 14:51–56.
   PubMed Web of Science ®Google Scholar
• Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. 2005. IL-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology. 68:138–145.
   PubMed Web of Science ®Google Scholar
• Lawrence S, Reid J, Whalen M. 2015. Secretion of IFNγ from human immune cells is altered by exposure to tributyltin and dibutyltin. Environ Toxicol. 30:559–571.
   PubMed Web of Science ®Google Scholar
• Loganathan B, Kannan K, Owen D, Sajwan K. 2000. Butyltin compounds in freshwater ecosystems. In: Lipnick RL, Hermens J, Jones K, Muir D, editors. Persistent, bioaccumulative, and toxic chemicals I. Fate and exposure. Washington, DC: American Chemical Society.
   Google Scholar
• Luo X, Yu Y, Liang A, Xie Y, Liu S, Guo J, Wang W, Qi R, An H, Zhang M, et al. 2004. Intratumoral expression of MIP-1β induces anti-tumor responses in pre-established tumor model through chemoattracting T-cells and NK cells. Cell Mol Immunol. 1:199–204.
   PubMed Web of Science ®Google Scholar
• Macarthur M, Hold GL, El-Omar EM. 2004. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 286:G515–G520.
   PubMed Web of Science ®Google Scholar
• Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M. 1990. Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med. 171:1797–1802.
   PubMed Web of Science ®Google Scholar
• Moudgil KD. 2015. Interplay among cytokines and T-cell subsets in the progression and control of immune-mediated diseases. Cytokine. 74:1–4.
   PubMed Web of Science ®Google Scholar
• Ogata N, Kouro T, Yamada A, Koike M, Hanai N, Ishikawa T, Takatsu K. 1998. JAK2 and JAK1 constitutively associate with an IL-5 receptor α and β subunit, respectively, and are activated upon IL-5 stimulation. Blood. 91:226–234.
   Web of Science ®Google Scholar
• Pelus LM, Fukuda S. 2006. Peripheral blood stem cell mobilization: The CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp Hematol. 34:1010–1020.
   PubMed Web of Science ®Google Scholar
• Sidiki A, Williams DT, Carrier R, Thomas B. 1996. Pilot study on the contamination of drinking water by organotin compounds from PVC materials. Chemosphere. 32:2389–2398.
   PubMed Web of Science ®Google Scholar
• Smialowicz RJ, Riddle MM, Rogers RR, Luebke RW, Copeland CB. 1989. Immunotoxicity of tributyltin oxide in rats exposed as adults or pre-weanlings. Toxicology. 57:97–111.
   PubMed Web of Science ®Google Scholar
• Song A, Nikolcheva T, Krensky AM. 2000. Transcriptional regulation of RANTES expression in T-lymphocytes. Immunol Rev. 177:236–245.
   PubMed Web of Science ®Google Scholar
• Steel JC, Waldmann TA, Morris JC. 2012. IL-15 biology and its therapeutic implications in cancer. Trends Pharmacol Sci. 33:35–41.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Tanabe S, Takeuchi I, Miyazaki N. 1999. Distribution and specific bioaccumulation of butyltin compounds in a marine ecosystem. Arch Environ Contam Toxicol. 37:50–61.
   PubMed Web of Science ®Google Scholar
• Tanabe S. 1999. Butyltin contamination in marine mammals: A review. Mar Poll Bull. 39:62–72.
   Web of Science ®Google Scholar
• Tanabe S, Prudente M, Mizuno T, Hasegawa J, Iwata H, Miyazaki N. 1998. Butyltin contamination in marine mammals from north Pacific and Asian coastal waters. Environ Sci Technol. 32:193–198.
   Web of Science ®Google Scholar
• Thomas LD, Shah H, Green SA, Bankhurst AD, Whalen MM. 2004. Tributyltin exposure causes decreased granzyme B and perforin levels in human natural killer cells. Toxicology. 200:221–233.
   PubMed Web of Science ®Google Scholar
• Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. 2003. IL-7 induces bone loss in vivo by induction of receptor activator of NF-κB ligand and TNFα from T-cells. Proc Natl Acad Sci USA. 100:125–130.
   PubMed Web of Science ®Google Scholar
• van Loveren H, Krajnc EI, Rombout PJ, Blummaert FA, Vos JG. 1990. Effect of ozone, hexachlorobenzene and bis(tri-n-butyltin)oxide on natural killer activity in the rat lung. Toxicol Appl Pharmacol. 102:21–33.
   PubMed Web of Science ®Google Scholar
• Whalen MM, Green SA, Loganathan B. 2002. Brief butyltin exposure induces irreversible inhibition of the cytotoxic function on human natural killer cells in vitro. Environ Res. 88:19–29.
   PubMed Web of Science ®Google Scholar
• Whalen MM, Loganathan BG, Kannan K. 1999. Immunotoxicity of environmentally-relevant concentrations of butyltins on human natural killer cells in vitro. Environ Res. 81:108–116.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). 1990. Tributyltin compounds. Environmental Health Criteria 116. Geneva: WHO.
   Google Scholar
• WHO (World Health Organization). 1999. International Program on Chemical Safety (IPCS) Concise International Chemical Assessment. Document 14: Tributyltin oxide. Geneva: WHO.
   Google Scholar
• Yanagawa H, Sone S, Haku T, Mizuno K, Yano S, Ohmoto Y, Ogura T. 1995. Contrasting effect of IL-13 on IL-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol. 12:71–76.
   PubMed Web of Science ®Google Scholar
• Yuan CH, Yang XQ, Zhu CL, Liu SP, Wang BC, Wang FB. 2014. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T-cells with induction of IFNγ in a murine breast cancer model. Asian Pac J Cancer Prev. 15:265–271.
   PubMedGoogle Scholar
• Zaidi MR, Merlino G. 2011. The two faces of IFNγ in cancer. Clin Cancer Res. 17:6118–6124.
   PubMed Web of Science ®Google Scholar
• Zhou J, Jin J, Du J, Yu Q. 2015. Innate immune signaling induces IL-7 production, early inflammatory responses, and Sjögren’s-like dacryoadenitis in C57BL/6 mice. Invest Ophthalmol Vis Sci. 56:7831–7838.
   PubMed Web of Science ®Google Scholar